See more news releases in Health Care & Hospitals | Medical Pharmaceuticals | Pharmaceuticals

Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013

EAST RUTHERFORD, N.J., Feb. 1, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that fourth quarter 2012 financial results will be released on Wednesday, February 6, 2013 after the market closes.

The Company will host a conference call to discuss the financial results.

	Fourth Quarter 2012 Earnings Conference Call

When:	Thursday, February 7, 2013 at 8:30 a.m. Eastern Time

Dial-in:	1-800-723-6604 for U.S.
	1-785-830-7977 for International
	Passcode: 6398974

Dial-in Replay:	1-888-203-1112 for U.S.
	1-719-457-0820 for International
	Passcode: 6398974
	Available through Thursday, February 14, 2013

Webcast:	www.cambrex.com

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation